Tag: LUCENT

Meaningful corticosteroid-sparing effect of mirikizumab in UC

Presented By
Prof. David Laharie, University of Bordeaux, France
Trial
Phase 3, LUCENT-2
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:22

LUCENT trials: Mirikizumab works in UC, regardless of targeted therapy history

Presented By
Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy
Trial
Phase 3, LUCENT-2
Conference
UEGW 2023
Type
Peer-reviewed article

7 December 2023 15:23

Ulcerative colitis: bowel urgency remission associated with improvement in fatigue

Presented By
Dr David Rubin, University of Chicago, IL, USA
Trial
Phase 3, LUCENT-1, LUCENT-2
Conference
DDW 2023
Type
News article

13 June 2023 13:52

Maintained symptom control with mirikizumab in UC

Presented By
Prof. Axel Dignass, Agaplesion Markus Hospital, Germany
Trial
Phase 3, LUCENT 2
Conference
UEGW 2022
Type
Peer-reviewed article

1 December 2022 21:49

Mirikizumab successfully resolves active histologic inflammation in UC

Presented By
Prof. Fernando Magro, CHU de São João, Portugal
Trial
Phase 2, LUCENT 2
Conference
UEGW 2022
Type
Peer-reviewed article

1 December 2022 21:44

IL-23 inhibition beneficial in maintenance treatment of UC

Presented By
Prof. Marla C. Dubinsky, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 3, LUCENT-2
Conference
DDW 2022
Type
News article

14 June 2022 22:01

ECCO 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ECCO 2022

8 March 2022 10:18
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com